XCUR Exicure, Inc. Common Stock

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

XCUR — —
Key stats
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
8
List Date
2018-05-09
CIK
0001698530
Next Earnings
2026-11-06
Headquarters
Chicago, IL
Homepage
https://www.exicuretx.com

Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indicatio…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan17.03%-11.68%2.92%-6.23%-26.02%-27.06%-8.51%
Feb0.00%-4.62%-15.94%31.52%-11.43%-10.95%-1.90%
Mar-0.46%-4.95%-22.92%-19.15%17.84%17.53%-2.02%
Apr-12.05%-23.75%12.40%-16.77%-20.83%-19.62%-13.44%
May-13.92%4.69%-18.43%-12.90%-1.00%-1.54%-7.18%
Jun-12.79%-43.97%49.39%-40.85%-32.70%-37.54%-19.74%
Jul-11.76%-21.74%-16.26%39.04%16.89%-19.19%-2.17%
Aug-22.65%19.61%-4.73%-20.39%-18.53%-17.09%-10.63%
Sep-12.41%-12.29%-20.88%78.72%-25.23%-8.47%-0.09%
Oct-2.59%-15.38%-15.09%-1.94%7.32%-7.63%*-5.89%
Nov-59.58%-32.43%-25.91%833.23%-0.71%--142.92%
Dec-56.95%13.30%23.44%-38.70%0.74%---11.63%
Total-92.21%-80.95%-55.23%374.47%-68.87%-78.62%-0.23%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.09
SMA 50: $1.22
SMA 200: $2.82
Current: $1.09
EMA 12: $1.09
EMA 26: $1.14
MACD: -0.0509 | Signal: 0.0082
BEARISH
ADX (14): 14.53
RANGE
+DI: 24.94
−DI: 18.92

Momentum Oscillators

RSI (14): 46.28
NEUTRAL
Stoch %K: 42.31
Stoch %D: 35.86
Williams %R: -57.69

Volume & Volatility

BB Upper: $1.22
BB Lower: $0.97
NEUTRAL
OBV: 82,907,998
Vol SMA 20: 62,631
Vol ROC: 135.22%
ATR: $0.12
True Range: $0.07
HV 20: 89.1%
HV 30: 79.6%
HV 60: 87.2%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary Overall assessment: NEUTRAL with confidence level (6/10) Key drivers: Recent positive news headlines, improving technical momentum Primary risks: Volatility, potential earnings miss Investment thesis: XCUR has shown signs of stabilization, driven by positive clinical trial results and co-development agreements. However, the stock remains volatile, and a potential earnings miss could lead to further price declines. Recent news sentiment impact: The recent positive news headlines have helped improve investor sentiment, leading to a moderate increase in the stock's price.

Technical Analysis Trend Direction:

  • Short-term (1-4 weeks): NEUTRAL
  • Medium-term (1-3 months): BULLISH
  • Long-term (3-12 months): BEARISH

Support/Resistance Levels:

  • Upper: $1.47 (Bollinger Bands upper band)
  • Middle: $1.30 (SMA 50)
  • Lower: $1.13 (Bollinger Bands lower band)

Momentum Signals:

  • RSI interpretation: NEUTRAL (40.75) - not oversold or overbought
  • MACD signal: BEARISH (bearish crossover)
  • Bollinger Bands position: MEAN REVERSION

Volume Analysis:

  • Volume SMA 20: 38969.48 (moderate volume)
  • On-Balance Volume (OBV): 129130730.39 (positive OBV signals)
  • Volume Rate of Change: -89.11% (high volatility)

News & Sentiment Analysis Recent Headlines Summary: Positive news headlines, including co-development agreements and clinical trial results, have dominated recent news.

Sentiment Assessment: Aggregate news sentiment: POSITIVE

Catalyst Identification: Upcoming events: Earnings announcements, potential FDA approvals

Market Narrative: The positive news has helped improve investor sentiment, aligning with the stock's technical momentum. However, the market remains cautious, and a potential earnings miss could lead to further price declines.

Risk & Volatility Assessment Beta Interpretation: Risk relative to market (beta 0.50) - low risk

Volatility Regime: Current vs historical volatility levels: MODERATE VOLATILITY

Options Market Signals: IV rank: N/A (no options data available) Put/call ratios: N/A (no options data available)

Downside Protection: Support levels and risk management considerations:

Market Context & Positioning Sector Performance: Relative strength vs sector/market: WEAK

Institutional Activity: Volume patterns suggesting institutional interest: MODERATE

Correlation Analysis: How stock moves relative to market (R-squared interpretation): 0.06 - low correlation

Relative Valuation: Position within trading range:

Key Levels & Action Items Critical Price Levels:

  • Support: $1.13 (Bollinger Bands lower band)
  • Resistance: $1.47 (Bollinger Bands upper band)

Breakout/Breakdown Levels:

  • Breakout level: N/A (no clear breakout level)
  • Breakdown level: N/A (no clear breakdown level)

Time-Sensitive Catalysts: Earnings announcements, potential FDA approvals

Risk Management: Stop-loss levels and position sizing considerations:

Recommendation Based on the analysis, I recommend a NEUTRAL stance, with a focus on monitoring the stock's technical momentum and news-driven catalysts. The recent positive news headlines have improved investor sentiment, but the stock remains volatile, and a potential earnings miss could lead to further price declines.

Generated

XCUR Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 0.0326
Alpha: -94.80%
Correlation: 0.0038
R-Squared: 0.0%
Stock Volatility: 108.7%
Market Volatility: 12.7%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time
Notable investors who own XCUR
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$31K
0.00%
#6104 of 6285new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

XCUR Institutional Ownership (13F)

Latest filings — 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

18 filers179,016 shares$512.40K value
# Filer Shares Value % of Total % of Float Period
1 Vanguard Group Inc Custodian 42,044 $227.88K 44.47% — 2025-12-31
2 Vanguard Capital Management LLC 43,111 $89.67K 17.50% — 2026-06-30
3 Geode Capital Management, LLC Custodian 31,249 $65.01K 12.69% — 2026-06-30
4 Jane Street Group, LLC Custodian 29,535 $61.43K 11.99% — 2026-06-30
5 Citadel Advisors LLC Custodian 14,919 $31.03K 6.06% — 2026-06-30
6 Vanguard Fiduciary Trust Co 13,161 $27.38K 5.34% — 2026-06-30
7 Tower Research Capital LLC (TRC) Custodian 4,074 $8.47K 1.65% — 2026-06-30
8 UBS Group AG Custodian 342 $711 0.14% — 2026-06-30
9 Morgan Stanley Custodian 143 $297 0.06% — 2026-06-30
10 SBI Securities Co., Ltd. 243 $289 0.06% — 2026-09-30
11 BlackRock, Inc. Custodian 35 $73 0.01% — 2026-06-30
12 OSAIC HOLDINGS, INC. Custodian 29 $60 0.01% — 2026-06-30
13 Prestige Wealth Management Group LLC 20 $42 <0.01% — 2026-06-30
14 HARBOUR INVESTMENTS, INC. 17 $35 <0.01% — 2026-06-30
15 Caitong International Asset Management Co., Ltd 6 $12 <0.01% — 2026-06-30
16 BNP Paribas Financial Markets Custodian 4 $8 <0.01% — 2026-06-30
17 JPMorgan Chase & Co Custodian 2 $4 <0.01% — 2026-06-30
18 Royal Bank of Canada Custodian 82 $0 0.00% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

XCUR Insider Trading (Form 4)

Latest: 2026-07-17
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-17 Exicure HiTron Inc. 10%+ Owner Other (J) +623,275 $4.50 $2.80M EDGAR
2026-02-19 Josh Miller Chief Accounting Officer Tax (F) −8 $4.08 -$33 EDGAR
2026-01-21 Exicure HiTron Inc. 10%+ Owner Sell (S) −258,367 $4.50 -$1.16M EDGAR
2026-01-20 Exicure HiTron Inc. 10%+ Owner Sell (S) −734,747 $4.50 -$3.31M EDGAR
2026-01-08 Exicure HiTron Inc. 10%+ Owner Sell (S) −741,272 $4.50 -$3.34M EDGAR
2025-12-10 SANGSANGIN INVESTMENT & SECURITIES CO., LTD. 10%+ Owner Sell (S) −433,332 $8.71 -$3.77M EDGAR
2025-11-19 Josh Miller Chief Accounting Officer Tax (F) −7 $3.71 -$26 EDGAR
2025-08-20 Josh Miller Chief Accounting Officer Tax (F) −9 $6.65 -$60 EDGAR
2025-05-23 Josh Miller Chief Accounting Officer Tax (F) −8 $10.06 -$80 EDGAR
2025-03-26 HiTron Systems Inc. 10%+ Owner Buy (P) +2,900,000 $3.00 $8.70M EDGAR
2025-02-24 Josh Miller Chief Accounting Officer Tax (F) −9 $10.03 -$90 EDGAR
2024-11-26 Josh Miller Chief Accounting Officer Tax (F) −7 $2.90 -$20 EDGAR
2024-09-16 DGP Co., Ltd. 10%+ Owner Buy (P) +237,223 $3.00 $711.7K EDGAR
2024-08-21 Josh Miller Chief Accounting Officer Tax (F) −38 $0.36 -$14 EDGAR
2024-05-23 Josh Miller Chief Accounting Officer Tax (F) −46 $0.52 -$24 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

XCUR Insider Holdings

2 insiders · @ $1.09
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Exicure HiTron Inc. 10%+ Owner 2,222,224 $2.42M $895.3K 5 2026-07-17
2 Josh Miller Chief Accounting Officer 301 $328 $0 12 2026-02-19
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

XCUR Board & Officers

As of SEC filings through Jul 17, 2026

Officers 1

  • Josh Miller · Chief Accounting Officer · listed since May 2023

10% owners 2

Changes in the last 10 years (96)
Mar 25, 2026The company announced the departure of Sangjin Yeo from the board in an SEC filing
Feb 6, 2026The company announced the departure of Seung Ik Baik from the board in an SEC filing
Feb 6, 2026The company announced the departure of Andy Yoo from the board in an SEC filing
Feb 6, 2026The company announced the departure of Aejin Hwang from the board in an SEC filing
Sep 8, 2025The company announced the departure of Sang Wook Song from the board in an SEC filing
Sep 8, 2025The company announced the departure of Min Woo Kang from the board in an SEC filing
Sep 8, 2025The company announced the departure of Ho Jung John from the board in an SEC filing
Sep 8, 2025The company announced the departure of Chang Keun Choi from the board in an SEC filing
Sep 8, 2025Sangjin Yeo became a director
Sep 8, 2025Aejin Hwang became a director
Dec 19, 2024Sang Wook Song became a director
Dec 19, 2024Min Woo Kang became a director
Dec 19, 2024Ho Jung John became a director
Dec 19, 2024Chang Keun Choi became a director
Dec 17, 2024The company announced the departure of Minhee Eom from the board in an SEC filing
Dec 17, 2024The company announced the departure of Hyuk Joon Ko from the board in an SEC filing
Dec 12, 2024Sangsangin Investment & Securities Co., Ltd. became a 10% owner
Nov 21, 2024The company announced the departure of Hojoon Lee from the board in an SEC filing
Nov 21, 2024Seung Ik Baik became a director
Nov 21, 2024Exicure HiTron Inc. became a 10% owner
Not reported recently (18)
  • Andy Yoo · Last reported as Chief Restructuring Officer in an SEC filing dated Nov 26, 2024
  • DGP Co., Ltd. · Last reported as a 10% owner in an SEC filing dated Sep 16, 2024
  • Dongho Lee · Last reported as a director in an SEC filing dated Jun 28, 2024
  • CBI USA, Inc. · Last reported as a 10% owner in an SEC filing dated Jun 27, 2023
  • Jung Sang Kim · Last reported as Chief Executive Officer, CFO in an SEC filing dated May 15, 2023
  • Uh Kang Paul Sung · Last reported as a director in an SEC filing dated Mar 6, 2023
  • Elias D. Papadimas · Last reported as Chief Accounting Officer in an SEC filing dated May 18, 2022
  • Douglas E. Feltner · Last reported as Chief Medical Officer in an SEC filing dated Nov 23, 2021
  • Brian Bock · Last reported as Chief Financial Officer in an SEC filing dated May 14, 2021
  • Jay Venkatesan · Last reported as a director in an SEC filing dated Jul 8, 2020
  • Chad A. Mirkin · Last reported as a director in an SEC filing dated Jun 16, 2020
  • Aurasense LLC · Last reported as a 10% owner in an SEC filing dated Jun 16, 2020
  • David R Walt · Last reported as a director in an SEC filing dated Jun 8, 2020
  • Helen Susan Kim · Last reported as a director in an SEC filing dated Jun 8, 2020
  • David S Snyder · Last reported as Chief Financial Officer in an SEC filing dated Mar 16, 2020
  • Colby Shad Thaxton · Last reported as a director in an SEC filing dated Jun 14, 2019
  • Ekambarswara R Kandimalla · Last reported as Chief Scientific Officer in an SEC filing dated Sep 28, 2017
  • Ian Seth Jacobs · Last reported as a director in an SEC filing dated Sep 26, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
1 ETF hold XCUR
1 shown · $33.22K total exposure
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VXF Vanguard Extended Market ETF Vanguard 0.00% $33,215 — 2026-09-30
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.